N-[(1,3-Dioxo-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinazolin-6-yl)methyl]-1-methyl-4-piperidinecarboxamide | 369594-57-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: N-[(1,3-Dioxo-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinazolin-6-yl)methyl]-1-methyl-4-piperidinecarboxamide
• 英文别名: N-[(2,4-dioxo-1,3-diazatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-11-yl)methyl]-1-methylpiperidine-4-carboxamide
• CAS: 369594-57-0
• 化学式: C₁₉H₂₄N₄O₃
• 分子量: 356.425
• InChiKey: ATZUPQWNGXSQHS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  81.8
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Tricyclic quinazolinediones
  申请人：——

  公开号：US20030105118A1

  公开（公告）日：2003-06-05

  A compound of the formula (1): 1 wherein —X 1 —X 2 — is a group of the formula: —C(═O)—N(R 7 )— or —C(R 8 )═N— (in which R 7 is hydrogen, substituted or unsubstituted alkyl, etc.; and R 8 is halogen, etc.); R 1 , R 2 and R 3 are independently hydrogen, substituted or unsubstituted alkyl, etc.; and R 4 is substituted or unsubstituted alkylene, or a prodrug thereof, or a pharmaceutically acceptable salt of the same, which exhibits an inhibitory activity of poly(ADP-ribose)polymerase (PARP) and is useful as remedies for diseases caused by the accelerated PARP activity such as brain ischemic disorders.

  式（1）的化合物：其中—X1—X2—是以下式的基团：—C(═O)—N(R7)—或—C(R8)═N—（其中R7为氢、取代或未取代的烷基等；R8为卤素等）；R1、R2和R3独立地为氢、取代或未取代的烷基等；R4为取代或未取代的亚烷基，或其前药，或其药用可接受的盐，该化合物具有对多聚(ADP-核糖)聚合酶（PARP）的抑制活性，并可用作用于由加速的PARP活性引起的疾病的药物，如脑缺血性疾病。
• TRICYCLIC QUINAZOLINEDIONES
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：EP1288216A1

  公开（公告）日：2003-03-05

  A compound of the formula (1): wherein -X1-X2- is a group of the formula: -C(=O)-N(R7)- or -C(R8)=N- (in which R7 is hydrogen, substituted or unsubstituted alkyl, etc.; and R8 is halogen, etc.); R1, R2 and R3 are independently hydrogen, substituted or unsubstituted alkyl, etc.; and R4 is substituted or unsubstituted alkylene, or a prodrug thereof, or a pharmaceutically acceptable salt of the same, which exhibits an inhibitory activity of poly(ADP-ribose)-polymerase (PARP) and is useful as remedies for diseases caused by the accelerated PARP activity such as brain ischemic disorders.

  式（1）的化合物： 其中 -X1-X2- 是式中的基团：-C(＝O)-N(R7)-或-C(R8)＝N-(其中 R7 是氢、取代或未取代的烷基等；R8 是卤素等)； R1、R2 和 R3 独立地是氢、取代或未取代的烷基等。R1、R2 和 R3 独立地是氢、取代或未取代的烷基等；R4 是取代或未取代的亚烷基，或其原药，或其药学上可接受的盐，对多（ADP-核糖）聚合酶（PARP）具有抑制活性，可用于治疗因 PARP 活性加速而引起的疾病，如脑缺血性疾病。